| SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues CGK Ziegler, SJ Allon, SK Nyquist, IM Mbano, VN Miao, CN Tzouanas, ... Cell 181 (5), 1016-1035. e19, 2020 | 2413 | 2020 |
| Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity WF Garcia-Beltran, EC Lam, KS Denis, AD Nitido, ZH Garcia, BM Hauser, ... Cell 184 (9), 2372-2383. e9, 2021 | 1503 | 2021 |
| SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2 TM Clausen, DR Sandoval, CB Spliid, J Pihl, HR Perrett, CD Painter, ... Cell 183 (4), 1043-1057. e15, 2020 | 1029 | 2020 |
| mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant WF Garcia-Beltran, KJS Denis, A Hoelzemer, EC Lam, AD Nitido, ... Cell 185 (3), 457-466. e4, 2022 | 1028 | 2022 |
| Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques NB Mercado, R Zahn, F Wegmann, C Loos, A Chandrashekar, J Yu, J Liu, ... Nature 586 (7830), 583-588, 2020 | 961 | 2020 |
| Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19 N Kaneko, HH Kuo, J Boucau, JR Farmer, H Allard-Chamard, ... Cell 183 (1), 143-157. e13, 2020 | 685 | 2020 |
| Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients AS Iyer, FK Jones, A Nodoushani, M Kelly, M Becker, D Slater, R Mills, ... Science Immunology 5 (52), 2020 | 680 | 2020 |
| COVID-19-neutralizing antibodies predict disease severity and survival WF Garcia-Beltran, EC Lam, MG Astudillo, D Yang, TE Miller, J Feldman, ... Cell 184 (2), 476-488. e11, 2021 | 655 | 2021 |
| Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic AG Edlow, JZ Li, YC Ai-ris, C Atyeo, KE James, AA Boatin, KJ Gray, ... JAMA Network Open 3 (12), e2030455-e2030455, 2020 | 384 | 2020 |
| Distinct early serological signatures track with SARS-CoV-2 survival C Atyeo, S Fischinger, T Zohar, MD Slein, J Burke, C Loos, DJ McCulloch, ... Immunity 53 (3), 524-532. e4, 2020 | 358 | 2020 |
| CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2 R Amraei, W Yin, MA Napoleon, EL Suder, J Berrigan, Q Zhao, J Olejnik, ... ACS Central Science 7 (7), 1156-1165, 2021 | 316 | 2021 |
| Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters LH Tostanoski, F Wegmann, AJ Martinot, C Loos, K McMahan, ... Nature medicine 26 (11), 1694-1700, 2020 | 302 | 2020 |
| In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies D Li, RJ Edwards, K Manne, DR Martinez, A Schäfer, SM Alam, K Wiehe, ... Cell 184 (16), 4203-4219. e32, 2021 | 288* | 2021 |
| Compromised humoral functional evolution tracks with SARS-CoV-2 mortality T Zohar, C Loos, S Fischinger, C Atyeo, C Wang, MD Slein, J Burke, J Yu, ... Cell 183 (6), 1508-1519. e12, 2020 | 285 | 2020 |
| Quick COVID-19 healers sustain anti-SARS-CoV-2 antibody production Y Chen, A Zuiani, S Fischinger, J Mullur, C Atyeo, M Travers, FJN Lelis, ... Cell 183 (6), 1496-1507. e16, 2020 | 192 | 2020 |
| Clinical sensitivity and interpretation of PCR and serological COVID‐19 diagnostics for patients presenting to the hospital TE Miller, WF Garcia Beltran, AZ Bard, T Gogakos, MN Anahtar, ... The FASEB Journal 34 (10), 13877-13884, 2020 | 149 | 2020 |
| Ultrasensitive high-resolution profiling of early seroconversion in patients with COVID-19 M Norman, T Gilboa, AF Ogata, AM Maley, L Cohen, EL Busch, ... Nature Biomedical Engineering, 1-8, 2020 | 144 | 2020 |
| Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike P Tong, A Gautam, I Windsor, M Travers, Y Chen, N Garcia, NB Whiteman, ... Cell 184 (19), 4969-4980, 2021 | 101 | 2021 |
| SARS-CoV-2-specific ELISA development V Roy, S Fischinger, C Atyeo, M Slein, C Loos, A Balazs, C Luedemann, ... Journal of Immunological Methods 484, 112832, 2020 | 85 | 2020 |
| An aluminum hydroxide: CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor-binding domain vaccine in aged mice E Nanishi, F Borriello, TR O’Meara, ME McGrath, Y Saito, RE Haupt, ... Science Translational Medicine, eabj5305, 2021 | 81* | 2021 |
